Diagnosis of early cervical cancer can be done more accurately in a minimally invasive manner. Further, costs of cervical cancer diagnosis can be significantly reduced.
About
Invention With this new system, diagnosis of early cervical cancer can be done more accurately in a minimally invasive manner. Further, costs of cervical cancer diagnosis can be significantly reduced. This invention presents a novel 3-D optical imaging system based on active stereo vision and motion tracking. The system can track the motion of patient and register the time-sequenced images of cervix recorded during the examination. This technology can quantify the acetic acid induced optical signals associated with early cancer development at cervix. Market Opportunity The imaging system can be easily integrated with a standard commercial colposcope for the diagnosis of early cervical cancer. The results of a preliminary clinical study of 65 patients at the Prince of Wales Hospital demonstrated that the accuracy to differentiate pre-cancerous cervical tissue from normal tissue can be significantly increased. In particular, the new technology does not require extensive training to operate and holds the potential to develop a fully automated system for accurate diagnosis of early cervical cancer. Collaboration partners could be medical equipment manufacturers which focus on developing equipment for accurate diagnosis of early cervical cancer. Key Benefits Easy to operate Higher accuracy Lower cost